person · Reporting owner

DUBIN THOMAS I H

Disclosed activity across 2 companies

Tapewire entity: 29477
SEC CIK: 0001231945

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
INTENSITY THERAPEUTICS, INC.INTS · Entity 7853	Director	July 16, 2026	July 20, 2026
Notable Labs, Ltd.NTBL · Entity 87239	Director	May 08, 2024	May 10, 2024

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

INTENSITY THERAPEUTICS, INC.

Report date July 16, 2026 · Filed July 20, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Stock Option (right to buy Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $4.90 · Expires 2036-07-16	Direct	5,500	Reported balance After 2026-07-16 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2026-07-16 · Grant · Acquired 5,500 · Balance 5,500 F1: This option will vest, subject to the individual's continued service with Intensity Therapeutics, Inc., in four, equal, annual installments, beginning on July 16, 2026.

Filing footnotes · ownership attribution and instrument terms

F1: This option will vest, subject to the individual's continued service with Intensity Therapeutics, Inc., in four, equal, annual installments, beginning on July 16, 2026.

Notable Labs, Ltd.

Report date May 08, 2024 · Filed May 10, 2024

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Ordinary SharesSEC Table I · non-derivative	Direct	40,247	Reported balance After 2024-05-08 transaction · row 1 1 source row Row 1 · 2024-05-08 · Grant · Acquired 40,247 · Balance 40,247 F1: Grant of restricted shares vesting in two equal annual installments from the date of grant.

Filing footnotes · ownership attribution and instrument terms

F1: Grant of restricted shares vesting in two equal annual installments from the date of grant.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
July 16, 2026 Filed Jul 20, 2026 20:04 UTC	INTENSITY THERAPEUTICS, INC. INTS · Entity 7853	GrantStock Option (right to buy Common Stock) · Derivative	5,500	$0.00 Strike: $4.90	$0.00	Disclosure SEC source: 0001231945-26-000002 · wk-form4_1784577849.xml · derivative · entry 1 DUBIN THOMAS I H · CIK 0001231945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,500 Underlying: Common Stock · 5,500 shares Expires 2036-07-16 F1 · derivative.exercise_date: This option will vest, subject to the individual's continued service with Intensity Therapeutics, Inc., in four, equal, annual installments, beginning on July 16, 2026. Read SEC document
May 02, 2025 Filed May 6, 2025 20:11 UTC	INTENSITY THERAPEUTICS, INC. INTS · Entity 7853	GrantStock Option (right to buy Common Stock) · Derivative	50,000	$0.00 Strike: $0.57	$0.00	Disclosure SEC source: 0001567264-25-000033 · wk-form4_1746562305.xml · derivative · entry 1 DUBIN THOMAS I H · CIK 0001231945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-05-02 F1 · derivative.exercise_date: This option will vest, subject to the individual's continued service with Intensity Therapeutics, Inc., in four, equal, annual installments, beginning on May 2, 2025. Read SEC document
May 14, 2024 Filed May 15, 2024 20:35 UTC	INTENSITY THERAPEUTICS, INC. INTS · Entity 7853	GrantStock Option (right to buy Common Stock) · Derivative	50,000	$0.00 Strike: $4.42	$0.00	Disclosure SEC source: 0001567264-24-000019 · wk-form4_1715805281.xml · derivative · entry 1 DUBIN THOMAS I H · CIK 0001231945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2034-05-14 F1 · derivative.exercise_date: This option will vest, subject to Mr. Dubin's continued service, in four equal annual installments beginning on May 14, 2024. Read SEC document
May 08, 2024 Filed May 10, 2024 21:09 UTC	Notable Labs, Ltd. NTBL · Entity 87239	GrantOrdinary Shares	40,247	$0.00	$0.00	Disclosure SEC source: 0001062993-24-009933 · form4.xml · nonDerivative · entry 1 DUBIN THOMAS I H · CIK 0001231945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,247 F1 · price: Grant of restricted shares vesting in two equal annual installments from the date of grant. Read SEC document
January 24, 2024 Filed Jan 26, 2024 16:02 UTC	Notable Labs, Ltd. NTBL · Entity 87239	GrantStock Option · Derivative	9,753	$0.00 Strike: $1.28	$0.00	Disclosure SEC source: 0001062993-24-001359 · form4.xml · derivative · entry 1 DUBIN THOMAS I H · CIK 0001231945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,753 Underlying: Ordinary Shares · 9,753 shares Expires 2034-01-24 F1 · derivative.exercise_date: Option vests 50% on the first anniversary of date of grant and thereafter in four equal quarterly installments ending on the second anniversary of the date of grant. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.